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One of the subjects that most concerns physicians is treatment-resistance. About 30%–60% of schizophrenia patients do not
respond adequately to antipsychotic treatment and are known as refractory schizophrenia patients. Clozapine has been the drug of
choice in such cases. However, approximately 30% of them do not respond to clozapine either. Here, we describe a patient with an
initial diagnosis of refractory schizophrenia who had a history of dramatic aggressiveness. However, in this case, “refractoriness”
was a wrong diagnosis. A case of psychosis secondary to epilepsy had been treated as schizophrenia for almost 20 years. Reports
like this one are important because they remind us of how a thorough investigation can lead to the correct diagnosis and improve
the patient’s prognosis.
1.Introduction
About 30%–60% of schizophrenia patients do not respond
adequately to antipsychotic treatment and are known as
refractory schizophrenia patients. Refractory schizophrenia
criteria were established based on Kane’s studies with
clozapine and modiﬁed by the The International Psychophar-
macology Algorithm Project (IPAP): (1) no period of good
functioning in the previous 5 years, (2) prior nonresponse to
atleast2antipsychoticdrugsoftwodiﬀerentchemicalclasses
for at least 4–6 weeks each at doses≥400mg equivalents of
chlorpromazineor5mg/dayofrisperidoneand(3)moderate
to severe psychopathology, especially positive symptoms.
Clozapine has been the drug of choice in such cases.
However, approximately 30% of them do not respond to
clozapine either [1, 2].
Sometimes we are forced to review our diagnostic steps.
This is the case when a patient’s psychiatric disorder does
not respond to treatments that were supposed to work. One
relevantstepinthereassessmentofthediagnosisistheexclu-
sion of an underlying medical condition. According to the
Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV-TR), the diagnosis of any psychiatric disorder requires
a thorough investigation and exclusion of possible general
medical causes that could better explain the symptoms.
Serious medical conditions may be overlooked when this
recommendation is disregarded [3].
In this case report, refractoriness was a wrong diagnosis.
A case of psychosis secondary to epilepsy had been treated as
schizophrenia for almost 20 years.
2. Case Presentation
Mr A, 38 years old, was referred for expert evaluation in
2005.Hehadanormaldevelopmentuntilhewaseight,when
he started to present irritability and soliloquies. At 19, he
began his psychiatric treatment due to agitation, visual and
auditory hallucinations, and delusions of persecution. He
was 25 when he beat his mother and was hospitalized for the
ﬁrst time.
The patient had already been treated with haloperidol
30mg/day, chlorpromazine 600mg/day, and risperidone
6mg/day .
He had no history of putative symptoms of epilepsy, such
as olfactory hallucinations or seizures. He had no history of
traumatic head injury or family history of seizures. However,
his 45-year-old brother had a stroke two years ago and one of
his cousins had a diagnosis of schizophrenia.2 Case Reports in Medicine
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Figure 1: EEG before valproate therapy showing bilateral sharp wave discharges.
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Figure 2: EEG after valproate therapy showing improvement of cerebral rhythms.
Mr A had been physically restrained at a traditional
psychiatric hospital for most of the previous year due to
recurrentepisodicaggressiveness.Thepsychiatristdescribed:
“The patient was hospitalized several times in the last years
due to his psychosis and aggressiveness. Few days after
discharge, he was brought back to the hospital after breaking
everything at home”; his brother added: “Many times my
family needed to have medical assistance as a consequence
of his violence.”
Bloodtests,serology(including VDRLandHIV),screen-
ing for drugs, EEG, Cerebral Tomography, and MRI showed
no abnormalities. Thus, following schizophrenia guidelines,
a clinical trial with olanzapine (a second-generation antipsy-
chotic) was suggested [4].Case Reports in Medicine 3
After almost one year, in November 2006, he was referred
to our inpatient unit with a diagnosis of clozapine-resistant
schizophrenia. He had been on clozapine 400mg/day for
eight months after failed trials with olanzapine (20mg/day)
and quetiapine (800mg/day).
In his ﬁrst weeks of hospitalization, the dose of clozapine
was increased up to 600mg/day. However, the patient con-
tinued presenting episodes of agitation and aggressiveness.
He said that he was haunted by his dead father. At these
moments, he would not respond to verbal interaction,
requiring the prescription of physical contention and paren-
theral sedative medications.
The patient would not attend the therapeutical activities
and had to be watched full time.
Sometimes he alleged he did not remember what hap-
pened. Sometimes, he tried to justify himself: “I’m sick, I
can’t control myself. I need to be tied up not to beat anyone.”
One day, after an episode in which he shouted out
obscenities and tried to punch a nurse, the patient presented
dizziness and sleepiness. Because of this peculiar pattern of
symptomsandhisunresponsivenesstoclozapine,weinsisted
on a 48-hour Video-EEG monitoring at our Epilepsy Center.
This new investigation revealed bilateral temporal parox-
ysm (Figure 1). Therefore, we changed our conduct by
starting valproate and gradually discontinuing clozapine.
Thepatientpresentedremissionofhisaggressivenessand
psychosis, started to attend the therapeutical activities, and
improved social interaction and self-care. Another Video-
EEG revealed improvement in the pattern observed in the
previous exam (Figure 2). He was discharged using valproate
2000mg/day (serum level: 88mg/L). When last contacted, in
March 2009, the patient was much better.
3. Discussion
Epilepsyiscommonlyassociatedwithpsychosis.Theseizures
are range variable and a routine EEG can be normal. Several
studies have suggested an association between these two
conditions. The frequency of psychosis has been reported to
behigherinpatientswithepilepsycomparedwiththegeneral
population [5, 6].
Discrimination based on the chronologic relation
between the psychotic episodes and seizures has been widely
used and includes: (a) interictal psychosis, in which the pres-
ence of psychotic episodes is not temporally related to the
occurrence of seizures; (b) postictal psychosis, characterized
by an increased number of seizures followed by a period of
lucidity and subsequent psychotic symptoms; and (c) ictal
psychosis, in which psychotic symptoms occur in association
with ictal discharges on EEG. Also, there are other kinds
of episodic symptoms that may mimic psychosis, including
nonconvulsive status epilepticus, postictal delirium, and
peri-ictal aggressive behavior [5].
Unfortunately, there is insuﬃcient biologic evidence
to support these chronology-based classiﬁcations of psy-
choses as distinct clinical entities. Some clinical features are
common to them and, over time, in some patients who
initially manifested postictal psychosis, interictal psychosis
develops. Actually, there is no consensus as to how those
cases should be classiﬁed [7–9]. However, we believe that
the most important message of this manuscript is that, when
evaluating a patient with psychiatric symptoms, it is essential
tobearinmindthepossibilityofageneralmedicalcondition.
This diﬀerential diagnosis cannot be forgotten even when in
the absence of exuberant neurological signs and symptoms.
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